Former England and Harlequins rugby sensation Ugo Monye is championing a revolutionary, non-invasive knee treatment as a superior alternative to surgery for ex-players suffering from debilitating joint pain. After enduring persistent knee issues post-retirement, the 42-year-old broadcaster found respite in a cutting-edge solution that sidesteps the need for surgical intervention.
Monye, who hung up his boots after a distinguished rugby career, described his transition from athlete to everyday struggles with mobility. "I had gone from playing elite-level rugby to then struggling to walk up and down the stairs and feeling older than what I actually am," he shared. Facing the prospect of knee replacement at just 41, Monye felt compelled to seek less drastic options. "I just thought there must be something intermediary between chronic pain and surgery," he said, "Surely there has to be something simpler?"
"It felt like a good immediate solution,"
Monye remarked after consulting with Dr. George Bownes FFSEM, the brain behind Citius Health. He was introduced to Arthrosamid®, a non-biodegradable, injectable hydrogel designed specifically for treating knee osteoarthritis. This innovative treatment not only promises elasticity restoration within the knee’s synovial tissue but also a significant pain reduction that can last up to five years following a single administration.
Dr. Bownes emphasized the longevity of natural knees, advocating for treatments that extend their functionality. "The best knee you have is the one you’re born with, and you want to keep that one going as long as you can," he advised. Over two decades of research back Arthrosamid®, making it a standout choice for those wary of the surgical route. The procedure itself is straightforward, requiring only local anesthesia and performed in a single visit.
Monye expressed his trust in the science and the relief it brought him, contrasting it sharply with the invasive nature of knee replacement surgery. "I trust the science behind what George was selling to me, and I couldn’t be any happier that I went for that because a new replacement is so drastic."
While skepticism initially clouded his decision, the long-term relief Monye experienced post-treatment was beyond his expectations. "I was still slightly skeptical because the condition my knee was in was severe and I thought it would be able to relieve the pain," he admitted, surprised by the duration of its effectiveness.
Arthrosamid® stands out not only for its simplicity but also for its durability compared to other treatments like steroids or hyaluronic acid, offering a cost-effective solution for those grappling with chronic knee pain. For ex-rugby players and athletes alike, this treatment might just be the game-changer they need to reclaim their mobility and quality of life.
2,100 posts
Former England and Harlequins rugby sensation Ugo Monye is championing a revolutionary, non-invasive knee treatment as a superior alternative to surgery for ex-players suffering from debilitating joint pain. After enduring persistent knee issues post-retirement, the 42-year-old broadcaster found respite in a cutting-edge solution that sidesteps the need for surgical intervention.
Monye, who hung up his boots after a distinguished rugby career, described his transition from athlete to everyday struggles with mobility. "I had gone from playing elite-level rugby to then struggling to walk up and down the stairs and feeling older than what I actually am," he shared. Facing the prospect of knee replacement at just 41, Monye felt compelled to seek less drastic options. "I just thought there must be something intermediary between chronic pain and surgery," he said, "Surely there has to be something simpler?"
"It felt like a good immediate solution,"
Monye remarked after consulting with Dr. George Bownes FFSEM, the brain behind Citius Health. He was introduced to Arthrosamid®, a non-biodegradable, injectable hydrogel designed specifically for treating knee osteoarthritis. This innovative treatment not only promises elasticity restoration within the knee’s synovial tissue but also a significant pain reduction that can last up to five years following a single administration.Dr. Bownes emphasized the longevity of natural knees, advocating for treatments that extend their functionality. "The best knee you have is the one you’re born with, and you want to keep that one going as long as you can," he advised. Over two decades of research back Arthrosamid®, making it a standout choice for those wary of the surgical route. The procedure itself is straightforward, requiring only local anesthesia and performed in a single visit.
Monye expressed his trust in the science and the relief it brought him, contrasting it sharply with the invasive nature of knee replacement surgery. "I trust the science behind what George was selling to me, and I couldn’t be any happier that I went for that because a new replacement is so drastic."
While skepticism initially clouded his decision, the long-term relief Monye experienced post-treatment was beyond his expectations. "I was still slightly skeptical because the condition my knee was in was severe and I thought it would be able to relieve the pain," he admitted, surprised by the duration of its effectiveness.
Arthrosamid® stands out not only for its simplicity but also for its durability compared to other treatments like steroids or hyaluronic acid, offering a cost-effective solution for those grappling with chronic knee pain. For ex-rugby players and athletes alike, this treatment might just be the game-changer they need to reclaim their mobility and quality of life.